{
    "2021-05-25": [
        [
            {
                "time": "",
                "original_text": "华东医药乌司奴单抗生物类似药进入临床三期，剑指300亿元国内银屑病市场",
                "features": {
                    "keywords": [
                        "华东医药",
                        "乌司奴单抗",
                        "生物类似药",
                        "临床三期",
                        "银屑病市场"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华东医药银屑病单抗即将Ⅲ期临床，原研药乌司奴单抗垄断将破？",
                "features": {
                    "keywords": [
                        "华东医药",
                        "银屑病单抗",
                        "Ⅲ期临床",
                        "乌司奴单抗",
                        "垄断"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "冲击乌司奴单抗全球首仿，华东医药重磅新药进入三期临床",
                "features": {
                    "keywords": [
                        "乌司奴单抗",
                        "全球首仿",
                        "华东医药",
                        "重磅新药",
                        "三期临床"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-06",
                "original_text": "华东医药（000963.SZ）：将于6月启动HDM3001产品（QX001S）Ⅲ期临床试验",
                "features": {
                    "keywords": [
                        "华东医药",
                        "HDM3001",
                        "QX001S",
                        "Ⅲ期临床试验",
                        "6月启动"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-06",
                "original_text": "华东医药（000963.SZ）：HDM3001产品（QX001S）将于6月开展Ⅲ期临床试验",
                "features": {
                    "keywords": [
                        "华东医药",
                        "HDM3001",
                        "QX001S",
                        "Ⅲ期临床试验",
                        "6月"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药企资本运作加快：跨界、并购、股权转让",
                "features": {
                    "keywords": [
                        "药企",
                        "资本运作",
                        "跨界",
                        "并购",
                        "股权转让"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "安信证券--商贸零售：4月社零同比增长19年同期8.8%，朗姿医美携手艾尔建美学开展国际战略合作【行业研究】",
                "features": {
                    "keywords": [
                        "安信证券",
                        "商贸零售",
                        "社零增长",
                        "朗姿医美",
                        "艾尔建美学",
                        "战略合作"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "商贸零售",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医美板块午前发力，华熙生物大涨9%",
                "features": {
                    "keywords": [
                        "医美板块",
                        "华熙生物",
                        "大涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华东医药大涨",
                "features": {
                    "keywords": [
                        "华东医药",
                        "大涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}